Preclinical Testing Shows Breezy aHP Activity Against Candida auris
Candida auris (C. auris) is an emerging multidrug-resistant fungus that is a growing concern for...
Stay up-to-date on Breezy Med and infection prevention automation with our press releases, blog articles, and case studies.
Candida auris (C. auris) is an emerging multidrug-resistant fungus that is a growing concern for...
Breezy Med is pleased to share the publication of a new peer-reviewed article in the Journal of...
Breezy Med is entering an exciting new chapter. Our automated aerosolized hydrogen peroxide (aHP)...
Carbapenem-resistant organisms (CROs) are among the most urgent threats...
At Breezy Med, we believe infection prevention should be both effective and measurable. To support...
We’re excited to welcome Mike Johnson as Breezy Med’s new Senior Sales Representative, serving ...
We're excited to announce that Breezy Med will be exhibiting at APIC25, the premier event for...
Breezy Med is proud to announce a strategic investment from CerraCap Ventures, a leading...
...
[Albuquerque, NM, March 2024] – Breezy Med has launched its first-ever partnership in the...
Discover an effective and convenient method of deodorizing with Aerosolized Hydrogen Peroxide (aHP)...